8-KOther EventsExhibits & Filings

CONSOLIDATED EDISON INC 8-K Report, Corporate Update (Jun 21, 2021)

Filed June 21, 2021For Securities:ED

Summary

Consolidated Edison, Inc. (Con Edison) announced on June 15, 2021, its entry into an underwriting agreement for the sale of 10,100,000 shares of its common stock. This offering is being conducted under a previously effective registration statement on Form S-3. The company has engaged Barclays Capital Inc. as the underwriter for this significant equity issuance. This filing primarily serves to disclose the details of the underwriting agreement and related exhibits, including legal opinions and consents concerning the common shares being offered. Investors should view this as an indication of Con Edison's strategic decision to raise capital through equity markets. While the specific use of proceeds is not detailed in this 8-K, such equity offerings are often utilized for general corporate purposes, funding capital expenditures, or reducing debt. Investors should monitor subsequent filings for further information on the deployment of these funds and the potential impact on the company's financial structure.

Key Highlights

  • 1Con Edison entered into an underwriting agreement on June 15, 2021.
  • 2The company plans to sell 10,100,000 shares of its common stock.
  • 3Barclays Capital Inc. is acting as the underwriter for the offering.
  • 4The sale of shares is registered under a Form S-3 registration statement.
  • 5The filing includes the underwriting agreement as an exhibit.
  • 6Legal opinions and consents related to the share issuance are also provided as exhibits.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce Consolidated Edison, Inc.'s (Con Edison) entry into an underwriting agreement to sell 10,100,000 shares of its common stock and to provide the related legal documentation as exhibits.

Con Edison is selling 10,100,000 shares of its common stock. Barclays Capital Inc. is the underwriter for this offering.

No, the shares being sold are registered under a previously effective registration statement on Form S-3 (No. 333-226538), which became effective on August 2, 2018.

This particular 8-K filing does not specify the exact use of proceeds from the sale of common shares. Such information is typically provided in other SEC filings or company communications.